For further details on the collaborations within the SFB-F61, SFB-F47 or SFB-F28 network grants please follow the links.
National
Prof. Fritz Aberger, University Salzburg, skin cancer and hedgehog signaling
Dr. Christoph Bock, CeMM – Research Center for Molecular Medicine of the Austrian Academy of Sciences, bioinformatics and genexpression analysis
Prof. Thomas Decker, MFPL Vienna, STAT1 in melanoma
Prof. Reinhold Erben, University of Veterinary Medicine, Vienna, Ewing´s sarcoma
Prof. Heinrich Kovar, CCRI Vienna, Ewing´s sarcoma
Dr. Robert Kralovics, CeMM – Research Center for Molecular Medicine of the Austrian Academy of Sciences, MPN mouse models
Dr. Stefan Kubicek, CeMM – Research Center for Molecular Medicine of the Austrian Academy of Sciences, chemical screening and metabolomics
Prof. Wolfgang Mikulits, Medical University Vienna, liver cancer
Prof. Mathias Müller, University of Veterinary Medicine, Vienna, Tyk2 and transgenesis
Prof. Thomas Rülicke, University of Veterinary Medicine, Vienna, mouse models
Prof. Veronika Sexl, University of Veterinary Medicine, Vienna, JAK-STAT in cancer, CML resistance mechanisms and CDK6
Prof. B. Strobl, University of Veterinary Medicine, Vienna, STAT1 signaling
Prof. Michael Trauner, Medical University Vienna, metabolism and liver cancer
Prof. Peter Valent, Medical University Vienna, MPN and leukemia
International
Prof. K.D. Bunting, Emory University, Atlanta, USA, interference with inhibitors of the PI3K-AKT-mTOR cascade in neoplastic cells
Prof. S. Constantinescu, Ludwig Cancer Institute, Bruessel, Belgium, p53 mutations and MPN
Prof. M. Deininger, Utah Huntsman CI, Salt Lake City, USA, STAT3/5 in the evolution and progression of CML and targeting them
Prof. K. Friedrich, Institute for Biochemistry, Friedrich Schiller University Jena, Jena, Germany, colorectal cancer
Prof. B. Groner, Georg-Speyer-Haus, Frankfurt, Germany, oncogenic STAT3/5
Prof. P. Gunning, University Toronto, SH2 domain inhibitors
Prof. X. Han, Cincinnati Children's Hospital Medical Center, Cincinnati, USA, and
Key Laboratory of Human Disease Comparative Medicine, Ministry of Health; the Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), Beijing, P.R. China
cytokine signaling in the GI tract for inflammatory and neoplastic disease
Prof. M. Heim and Prof. L. Terracciano, University Hospital Basel, Basel, Switzerland, liver cancer and metabolism
Prof. L. Hennighausen and Prof. J. O´Shea, NIH, Washington, USA, immunity, mouse models of STAT function
Prof. F. Gouilleux, Université Rabelais, Tours, France, STAT5 in leukemogenesis and PI3K-AKT-mTOR signaling
Prof. AT. Look, Dana Farber, Boston, USA, T-cell leukemia and mutated JAK kinases
Prof. G. Müller-Newen, RWTH Aachen, Deutschland, STAT5 shuttling in CML and AML
Prof. W. Priebe, MD Anderson Cancer Center, USA, inhibitors of transcription factors
Prof. W. Tse, James Graham Brown Cancer Center, Louisville, Kentucky, USA, AF1q in MetastasisAF1q in breast cancer metastasis
Prof. J. Tuckermann, University Ulm, Ulm, Germany, GR-STAT5 in hematopoietic cells and for metabolic control
Prof. K.U. Wagner, Eppley Institute for Research in Cancer and Allied Diseases, Omaha, USA, JAK2-STAT5 signaling and transgenic mouse models